Sep/Oct 2001 - Bioidentical Hormone Replacement Therapy

Purchase or view individual articles by selecting the article in the table below...

Individual Articles - Sep/Oct 2001 - Bioidentical Hormone Replacement Therapy

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2001 Pg. 332-335 View Sample	Natural Hormone Replacement Therapy: What It Is and What Consumers Really Want Author(s): Reed-Kane Dana
Sep/Oct 2001 Pg. 336-338	Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment Author(s): Lorentzen Jean
Sep/Oct 2001 Pg. 339-341	Bioidentical Hormones in the Treatment of Osteoporosis Author(s): Boomsma Diane
Sep/Oct 2001 Pg. 342-344	The Value of Hormone Assessment Author(s): Collins Joseph J
Sep/Oct 2001 Pg. 346-350	Estrogen Replacement: A Review of Current Literature Author(s): Parazewski Kevin
Sep/Oct 2001 Pg. 351-353	Treating Andropause: Prohormones and Hormone Metabolic Modifiers Author(s): Biundo Bruce
Sep/Oct 2001 Pg. 354-355	Bioidentical Topical Progesterone: A Survey of Patients Author(s): Warren Aileen, Listecki Robert E
Sep/Oct 2001 Pg. 356-357	Book Reviews: Hormone Replacement Therapy Author(s): Paoletti James E
Sep/Oct 2001 Pg. 360-361	Charting Systems: Organizing Information Effectively Author(s): Anneken Michael W, Flick Celeste C
Sep/Oct 2001 Pg. 362-364	Minimizing the Risk of Cholesterol-Lowering Therapy Author(s): Pratt Sam
Sep/Oct 2001 Pg. 365-367	Compounding in History: Treatment at the Change of Life Author(s): Worthen Dennis B
Sep/Oct 2001 Pg. 366	Flush Powder, No. 2 Author(s): Worthen Dennis B
Sep/Oct 2001 Pg. 366	Tincture of Black Cohosh Author(s): Worthen Dennis B
Sep/Oct 2001 Pg. 366	Lydia Pinkham's Vegetable Compound Author(s): Worthen Dennis B
Sep/Oct 2001 Pg. 369-371	The Basics of Compounding: Tablets and Pills Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 374	Estriol 2-mg/mL and Estradiol 0.5-mg/mL in Pluronic Lecithin Organogel (PLO) Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 375	Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 376	Libido Cream Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 377	Progesterone 50-mg/mL Clear Topical Solution Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 378	Progesterone Low-Potency 0.0065% Topical Cream Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 379	Sildenafil 1% Topical Cream Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 380	Testosterone 1-mg/0.1-mL Pluronic Lecithin Organogel (PLO) Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 381	Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 382	Testosterone 25-mg/mL Clear Solution Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 383	Testosterone 2% Scalp Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 384-388	Compounding Containment Devices: Buyer Be Aware Author(s): Kastango Eric S
Sep/Oct 2001 Pg. 389-390	Capsule and Tablet Disintegrating Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 391	Calculations Author(s): Prince Shelly J
Sep/Oct 2001 Pg. 392-393	Developing a Capsule Formulation Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 394-396	Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes Author(s): Storms Meredith L, Stewart James T, Warren Flynn W
Sep/Oct 2001 Pg. 397-400	Assessment of the Stability of Teicoplanin in Intravenous Infusions Author(s): Galanti Laurence M, Hecq Jean-Daniel, Jeuniau Philippe, Vanbeckbergen Danielle, Jamart Jacques
Sep/Oct 2001 Pg. 401-405	Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release Author(s): Bogner Robin H, Szwejkowski Jessica, Houston Alana
Sep/Oct 2001 Pg. 408	PostScription: Compounding Errors: Lessons Learned, Never To Be Forgotten Author(s): Allen Loyd V Jr